Blood biomarkers could detect earliest signs of Alzheimer’s disease – and slow its progression
By Ashleigh Barrett-Young* of Photo: 123RF Alzheimer’s disease, a progressive neurodegenerative dysfunction that impacts hundreds of thousands worldwide, has a protracted preclinical stage. It probably begins a long time earlier…